ADAM J. WOLFBERG, MD, MPH
89 Revere St.
Boston, MA 02114
awolfberg@tuftsmedicalcenter.org
ajwolfberg@gmail.com
617/699-1022
________________________________________________________________
EDUCATION:
Johns Hopkins School of Medicine, Baltimore, MD
Doctor of Medicine, 2001
Johns Hopkins School of Public Health, Baltimore, MD
Masters in Public Health, 1997
Georgetown University, Washington, DC
Bachelor of Arts and Sciences, 1992, Magna Cum Laude
Majors: History & English
PROFESSIONAL EXPERIENCE:
Tufts Medical Center, Department of Obstetrics & Gynecology, Tufts University
School of Medicine
Assistant Professor of Maternal-Fetal Medicine
September 2009 - Present
Tufts Medical Center, Department of Obstetrics & Gynecology
Fellow in Maternal-Fetal Medicine
July 2006 – June 2009
Boston Children’s Hospital, Department of Neurology, Harvard Medical School
Research Fellow
August 2005 – November 2010
Brigham and Women’s Hospital and Massachusetts General Hospital,
Departments of Obstetrics & Gynecology
Resident Physician
June 2001 – June 2005
Primary Care Policy Center, Johns Hopkins School of Hygiene and Public Health
Research Assistant
January 1997 to January 1998
Cooper Green Hospital, Birmingham, Alabama
Senior Administrative Intern. Developed an AmeriCorps program, did policy work
related to development of a Medicaid 1115 waiver, designed an evaluation of a
managed-care program for Birmingham’s public hospital.
April 1997 - August 1997
Alabama Community Health Care Network, Montgomery, Alabama
Project Director. Responsible for directing this corporation’s efforts to build an
HMO targeting Alabama’s Medicaid population. The non-profit corporation, owned
by Franklin Memorial and the state’s 16 other Community Health Centers, was
chartered in 1994 to ease their transition into managed care.
January 1996 - July 1996
Franklin Memorial Primary Health Care Center, Mobile, Alabama
Director of Special Projects. Responsible for preparing Franklin’s four health clinics
to remain viable in the future. Duties also include oversight of a health center,
negotiation of managed care contracts and a Medicaid 1115 waiver, coordination
of managed care initiatives for the Alabama Primary Health Care Association.
March 1995 - January 1996
Mobile Press Register, Mobile, Alabama
Health Reporter. Responsible for coverage of health issues including public health
stories, Mobile’s medical community, advancements in medicine, and the impact of
local and national health-care reform initiatives on Alabama. Also responsible for
occasional general assignment stories. Received several awards and was nominated
for the 1995 Pulitzer Prize.
September 1993 - March 1995
Newsweek, Washington, DC
Reporter. Half-time spent as a general assignment reporter in the Washington
bureau. Half-time spent conducting research for Bureau Chief Evan Thomas who
was writing a history of the Central Intelligence Agency.
September 1992 - August 1993
Congressman Sander Levin, D-MI,
Campaign Staff. Duties included developing media strategies, advance work,
coordinating advertising.
Summer 1992
AWARDS, HONORS, CERTIFICATIONS, & MEMBERSHIPS:






Fellow, American College of Obstetricians and Gynecologists (Board Certified 2010)
Boston Obstetrics Society
Young Investigator, The Perinatal Research Society. 2010
Fellow, NICHD Aspen Conference on Maternal-Fetal-Neonatal-Reproductive Medicine,
2006
Resident Teaching Award. Brigham and Women’s Hospital. Boston, MA, 2002 & 2004
Teaching Award, Tufts University School of Medicine, Boston, MA. 2007
LANGUAGE:
Spanish
GRANT SUPPORT:
• Training Grant 2000-2002
Centers for Disease Control and Prevention, Association of Teachers of Preventive
Medicine
Dads as Breastfeeding Advocates. A training grant from the CDC funded a pilot study
evaluating an educational intervention to promote breastfeeding.
Role: Principal Investigator
• William Randolph Hearst Fund of Harvard Medical School. 2006-2009.
Clinical testing of magnetic resonance imaging sequences in the fetus
Role: Principal Investigator.
• Obstetrix Research Award 2007
The Safe Fetus Project
Role: Principal Investigator
• Small Science Award 2008-2009
CIMIT
The Safe Fetus Project.
Role: Principal Investigator
• Tufts Medical Center 2009-2010
Research Award
The Safe Fetus Project
Role: Principal Investigator
• SBIR NICHD (1R43HD59263-01A) 2009
Orbital Research, Inc.
NONA: Noninvasive Observation of Natal Activity
Role: Co-investigator
• K-23 NICHD (1K23HD060662-01A1) 2010-2015
The Safe Fetus project
Role: Principal Investigator
PEER-REVIEWED PUBLICATIONS:
• Wolfberg AJ, Frick K, Dievler A, Michael M. A managed care insurance product for the
uninsured: a case study. Journal of Health Care for the Poor and Underserved.
2000.11:5-18.
• Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease
with preeclampsia. Obstetrics & Gynecology. 2004. 103:1190-3.
• Wolfberg AJ, Montz F, Bristow R. The role of obesity in the surgical management of
advanced-stage ovarian cancer. Journal of Reproductive Medicine. 2004. 49:473-6.
• Wolfberg AJ, Michels KB, Shields W, O’Campo P, Bronner Y, Bienstock J. Dads as
breastfeeding advocates- results from a randomized controlled trial of an educational
intervention. American Journal of Obstetrics and Gynecology. 2004. 191:708-12.
• Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman ES. Low risk of relapse
after achieving non-detectable hCG levels in women with complete molar pregnancy.
Obstetrics & Gynecology. 2004. 104:551-4.
• Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Obstetric and neonatal outcomes
associated with maternal hypothyroid disease. Journal of Maternal-Fetal and Neonatal
Medicine. 2005. 17:35-38.
• Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman ES. Post-evacuation hCG
Levels and Risk of Gestational Trophoblastic Neoplasia. Obstetrics &Gynecology. 2005.
106:548-52.
• Wolfberg AJ, Growdon WB, Feltmate C, Goldstein DP, Genest D, Chinchilla ME, Berkowitz
RS Lieberman ES. Low risk of relapse after achieving undetectable HCG levels in
women with partial molar pregnancy. Obstetrics & Gynecology. 2006. 108:393-6.
• Growdon WB, Wolfberg AJ, Feltmate C, Goldstein DP, Genest D, Chinchilla ME, Berkowitz
RS, Lieberman E. Post-evacuation hCG levels and risk of gestational trophoblastic
neoplasia among women with partial molar pregnancies. Journal of Reproductive
Medicine, 2006. 51:871-4.
• Feltmate C, Growdon WB, Wolfberg AJ, Goldstein DP, Genest D, Chinchilla ME, Lieberman
E, Berkowitz RS. Clinical characteristics of persistent gestational trophoblastic neoplasia
after partial hydatidiform molar pregnancy. Journal of Reproductive Medicine, 2006.
51:902-6.
• Wolfberg AJ, Robinson JN, Mulkern R, Rybicki F, du Plessis AJ. Identification of fetal
cerebral lactate using magnetic resonance spectroscopy. American Journal of Obstetrics
and Gynecology. 2007. 196:e9-11.
• Wolfberg AJ, DeRosier DJ, Roberts T, Syed Z, Clifford GD, Acker DA, du Plessis AJ. A
comparison of subjective and mathematical estimations of fetal heart rate variability.
Journal of Maternal-Fetal and Neonatal Medicine. 2008. 21:101-104.
• Boissel L, Tuncer HH, Betancur M, Wolfberg A, Klingemann H. Umbilical cord mesenchymal
stem cells increase expansion of cord blood natural killer cells. Biol Blood Marrow
Transplant. 2008. 14:1031-8.
• Papaliodis D, Boucher W, Kempuraj D, Michaelian M, Wolfberg A, House M, Theoharides
TC. Niacin-induced “flush” involves release of prostaglandin D2 from mast cells and
serotonin from platelets: evidence from human cells in vitro and an animal model. J
Pharmacol Exp Ther. 2008. 327:665-72.
• Kempuraj D, Tagen M, Iliopoulou BP, Clemons A, Vasiadi M, Boucher W, House M,
Wolfberg A, Theoharides TC. Luteolin inhibits myelin basic protein-induced human mast
cell activation and mast cell-dependent stimulation of Jurkat T cells. Br J Pharmacol.
2008. 155:1076-84.
• Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES,
Berkowitz RS. Evaluating methotrexate treatment in patients with low-risk postmolar
gestational trophoblastic neoplasia. Gynecol Oncol. 2009. 112:353-7.
• Mok-Lin EY, Wolfberg A, Hollinquist H, Laufer MR. Endometriosis in a patient with MayerRokitansky-Kuster-Hauser Syndrome and complete uterine agenesis: evidence to
support the theory of coelomic metaplasia. J Pediatr Adolesc Gynecol. 2009. July 7.
• Vasiadi M, Kalogeromitros D, Kempuraj D, Clemons A, Zhang B, Chliva C, Makris M,
Wolfberg A, House M, Theoharides TC. Rupatadine inhibits proinflammatory mediator
secretion from human mast cells triggered by different stimuli. Int Arch Allergy Immunol.
2009. 151:38-45.
• Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES,
Berkowitz RS. Low-risk gestational trophoblastic neoplasia and methotrexate resistance:
predictors of response to treatment with actinomycin D and need for combination
chemotherapy. J Reprod Med. 2010. 55:279-84.
 Clifford G, Sameni R, Ward J, Robinson J, Wolfberg A. Clinically accurate fetal ECG
parameters acquired from maternal abdominal sensors. Am J Obstet Gynecol. 2011.
205: 47.e1-47.e5.
OTHER PUBLICATIONS:
• Wolfberg AJ. Money matters. Medscape.com 2000.
• Wolfberg AJ, Vlahos N. Transdermal estrogen therapy. Postgraduate Obstetrics and
Gynecology. 2000. 12:1-6.
• Wolfberg AJ. Volunteering overseas – lessons from surgical brigades. New England Journal
of Medicine. 2006. 354:443-5.
• Wolfberg AJ, du Plessis AJ. Near infrared spectroscopy in the fetus and neonate. Clinics in
Perinatology. 2006. 33:707-28.
• Wolfberg AJ. Genes on the Web – Direct to consumer marketing of genetic testing. New
England Journal of Medicine. 2006. 355:543-5.
• Wolfberg AJ. Patient as ally – learning the pelvic exam. New England Journal of Medicine.
2007. 356:889-90.
• Wolfberg AJ, Dammann O, Gressens P. Anti-inflammatory and immunomodulatory
strategies to protect the perinatal brain. Seminars in Fetal and Neonatal Medicine. 2007.
12:296-302
• Wolfberg AJ. Hyppocritical Doctors. Boston Globe Magazine. March 25, 2007.
• Wolfberg AJ. Extreme Preemies. Boston Globe Magazine. April 26, 2008.
• Wolfberg AJ. What if your fetus has Down syndrome. Boston Globe Magazine. February
15, 2009.
• Wolfberg AJ. Test poses challenge for OB/GYNs. Wall Street Journal online. June 8, 2009.
• Wolfberg AJ, Norwitz ER. Probing the fetal cardiac signal for antecedents of brain injury.
Clin Perinatol. 2009. 36:673-84.
• Wolfberg AJ. Live from the O.R. The problems with broadcasting surgeries as they happen.
Slate.com. August 18, 2009.
• Wolfberg AJ, Bianchi D. Prenatal diagnosis using cell-free fetal nucleic acids in maternal
blood. UpToDate.com. Posted beginning in Edition 17.3. November 2009.
ABSTRACTS AND PRESENTATIONS:
• Wolfberg A, Bienstock J, Shields W. The baby-care project: description of a breastfeeding
promotion intervention. American Public Health Association annual meeting. November
2001.
• Shields W, Wolfberg A, Bienstock J, O’Campo, Spruill J, Bronner Y. Turning dads into
breastfeeding advocates – a pilot study from Baltimore City. American Public Health
Association. Philadelphia, PA. November 2002.
• Wolfberg A. Nagey, D. Maternal thyroid disease during pregnancy and subsequent
congenital anomalies. Society of Maternal Fetal Medicine. New Orleans, LA. February
2002.
• Wolfberg A, Bienstock J, O’Campo, Shields W, Spruill J, Bronner Y. Turning dads into
breastfeeding advocates – preliminary data. Society of Maternal Fetal Medicine. San
Francisco, CA. February 2003.
• Wolfberg A, Hallonquist, H, Laufer, M. Endometriosis in a young woman with MRKH
syndrome and uterine agenesis. National Society for Pediatric and Adolescent
Gynecology annual meeting. May 2003
• Wolfberg A, Lieberman E, Feltmate C, Goldstein D, Berkowitz R. Trophoblastic disease
does not persist once hCG titres decline to less than 5 mIU/ml. XIIth International
Congress on Gestational Trophoblastic Disease. Boston, MA. October 2003.
• Wolfberg A, Lee-Parritz A, Holmes L, Lieberman, E. Maternal hypothyroid disease is not
associated with poor obstetric or neonatal outcomes. Society for Maternal Fetal
Medicine. New Orleans, LA. February 2004
• Feltmate C, Wolfberg A, Lieberman E, Goldstein D, Berkowitz R. Trophoblastic disease
does not persist once hCG titres decline to less than 5 mIU/ml. Society of Gynecologic
Oncologists. San Diego, CA. February 2004.
• Wolfberg A, Schust D, Berkowitz L. Development and preliminary evaluation of a
formalized mentoring program for OB/GYN residents. Counsel on Resident Education in
Obstetrics and Gynecology, Association of Professors of Gynecology and Obstetrics. Salt
Lake City, UT. March 2005.
• Wolfberg A, Mulkern R, du Plessis A, Rybicki F, Tempany C, Robinson JN. In-utero fetal
metabolic analysis using proton magnetic resonance spectroscopy. International Society
of Perinatal Obstetricians. Dublin, Ireland. May 2005.
• Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Growdon W, Lieberman ES. Postevacuation hCG Levels and Risk of Gestational Trophoblastic Neoplasia. XIIIth
International Congress on Gestational Trophoblastic Disease. Hong Kong, China. October
2005.
• Growdon W, Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman ES. Partial
molar pregnancies do not persist once hCG reaches undetectable levels. XIIIth
International Congress on Gestational Trophoblastic Disease. Hong Kong, China. October
2005.
• Growdon W, Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman ES. Postevacuation hCG levels and the risk of gestational trophoblastic neoplasia among women
with partial molar pregnancies. XIIIth International Congress on Gestational
Trophoblastic Disease. Hong Kong, China. October 2005.
• Feltmate C, Genest D, Wolfberg AJ, Growdon W, Goldstein D, Lieberman E, Berkowitz R.
Clinical Characteristics of Persistent Gestational Trophoblastic Neoplasia following
Partial Hydatidiform Molar Pregnancy. XIIIth International Congress on Gestational
Trophoblastic Disease. Hong Kong, China. October 2005.
• Chapman E, Robinson J, Benson CB, Wolfberg AJ. Association of Umbilical Cord Cysts and
Congenital Anomalies. Society of Maternal Fetal Medicine. Miami, FL. February 2006.
• Chapman E, Robinson J, Benson CB, Wolfberg AJ. Association of Umbilical Cord Cysts and
Congenital Anomalies. Association of Ultrasound In Medicine. Washington, DC. March
2006.
• Growdon W, Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman ES. Postevacuation hCG levels and the risk of gestational trophoblastic neoplasia among women
with partial molar pregnancies. Society of Gynecologic Oncologists. Palm Springs, CA.
March 2006.
• Growdon W, Wolfberg AJ, Lieberman E, Goldstein D, Feltmate F, Berkowitz R. Predicting
the Need for Additional Courses of Chemotherapy in Patients with Low Risk Gestational
Trophoblastic Neoplasia after Initial Course of Methotrexate Chemotherapy. Society of
Gynecologic Oncologists. Palm Springs, CA. March 2006.
• Wolfberg AJ, DeRosier D, Roberts T, Syed Z, Acker DA, du Plessis, AJ. Validation of a
computer algorithm that measures fetal heart rate variability. New England Conference
on Perinatal Research. Newport, RI. September 2006.
• Wolfberg AJ, DeRosier D, Roberts T, Syed Z, Acker DA, du Plessis, AJ. Development of a
computer-based algorithm to distinguish minimal from moderate fetal heart rate
variability. Society of Maternal Fetal Medicine. San Francisco, CA. February 2007.
• Papadopolous D, Berman S, Wolfberg A. Factors contributing to physician anxiety about
medical malpractice litigation. New England Perinatal Society. Newport, RI. April 2007.
• Wolfberg AJ, Syed A, Clifford G, Tin A, Guttag J, du Plessis AJ. Entropy of fetal EKG
associated with intrapartum fever. New England Conference on Perinatal Research.
Chatham, MA. October 2007.
• Papadopoulos D, Berman S, House M, Wolfberg, AJ. Obstetricians’ reactions to the threat
of medical malpractice litigation. Society for Maternal-Fetal Medicine. Dallas, TX.
January 2008.
• Wolfberg AJ, Syed Z, Clifford G, DeRosier D, Tin A, du Plessis AJ. Entropy of fetal EKG
associated with intrapartum fever. Society for Maternal-Fetal Medicine. Dallas, TX.
January 2008.
• Mackay G, House M, Bloch E, Wolfberg, AJ. A GBS culture collected after antibiotic
administration may be inaccurate. Society for Maternal-Fetal Medicine. San Diego, CA.
January 2009
• Ranganath S, Durfee S, Katz D, Pettigrew C, Jennings R, Ecker J, House M, Benson C,
Wolfberg AJ. Accuracy of ultrasound to predict estimated weight in fetuses with
gastroschisis. Society for Maternal-Fetal Medicine. San Diego, CA January 2009.
• Ranganath S, Durfee S, Katz D, Pettigrew C, Jennings R, Ecker J, House M, Benson C,
Wolfberg AJ. Accuracy of ultrasound to predict estimated weight in fetuses with
gastroschisis. New England Perinatal Society. Newport, RI. March 2009
• Pettigrew C, Ranganath S, Durfee S, Katz D, Jennings R, Ecker J, House M, Benson C,
Wolfberg AJ. Effect of delivery prior to 36 weeks’ gestational age on outcome of patients
with gastroschisis. New England Perinatal Society. Newport, RI. March 2009.
• Wolfberg A, du Plessis A, Robertson R, House M, Loberg A, Pettigrew C, Bhadelia R,
Mulkern R. Proton spectroscopy of the fetal brain: an assessment of feasibility in 22
cases. New England Perinatal Society. Newport, RI. March 2009.
• Syed Z, Wolfberg A, Guttag, J. Association of Morphologic Entropy in Fetal
Electrocardiograms with Inflammatory Cytokines and Markers of Neuronal Injury.
Society for Maternal-Fetal Medicine. Chicago, IL. February 2010.
• Sameni R, Clifford G, Ward J, Robertson J, Pettigrew C, Wolfberg A. Accuracy of fetal heart
rate acquired from sensors on the maternal abdomen compared to a fetal scalp
electrode. Society for Maternal-Fetal Medicine. Chicago, IL. February 2010.
• Clifford G, Sameni R, Ward J, Robertson J, Pettigrew C, Wolfberg A. Comparing the fetal
ST-segment acquired using a FSE and abdominal sensors. Society for Maternal-Fetal
Medicine. Chicago, IL. February 2010.
• Wolfberg A, Pettigrew C, Loberg A, House M, Bhadelia R, Robertson R, du Plessis A,
Mulkern B. Proton Magnetic Resonance Spectroscopy of the Fetal Brain: An Assessment
of Clinical Feasibility. Society for Maternal-Fetal Medicine. Chicago, IL. February 2010.
• Wolfberg A, Drohan B, Hughes K, Cooley S, Pettigrew C, Hassan L, Robinson J. Evaluation
of a tablet PC-based survey and educational tool for prenatal diagnosis and aneuploidy
screening. New England Perinatal Society. Newport, RI. March 2010.
• Wolfberg A, Arigita M, Comas M, Soler A, Borrell A. Do biopsy forceps or the aspiration
cannula produce a better chorionic villus sampling specimen? New England Perinatal
Society. Newport, RI. March 2010.
• Hall L, Hannon D, House M, Wolfberg A, Leisk G. Prototype electronic displays for
improved visual interpretation of fetal heart rate variability. 3rd International
Conference on Applied Human Factors and Ergonomics. Miami, FL. July 2010.
 Heard A, Iyer C, Coletta J, Panda B, Scholl J, Al Ammari R, Kaplan J, Tanner CE , House MD,
Craigo SD, Wolfberg AJ, The influence of nuchal translucency thickness on the risk of
structural abnormalities. Society for Maternal-Fetal Medicine. San Francisco, CA.
February 2011.
 Heard A, Iyer C, Coletta J, Panda B, Scholl J, Al Ammari R, Kaplan J, Tanner CE, House MD,
Craigo SD, Wolfberg AJ, A cystic hygroma increases the risk of abnormalities among 397
women diagnosed with a thickened nuchal translucency. Society for Maternal-Fetal
Medicine. San Francisco, CA. February 2011.
 Iyer C, Heard A, Coletta J, Panda B, Scholl J, Al Ammari R, Kaplan J, Tanner CE, House MD,
Craigo SD, Wolfberg AJ, The Incidence of Aneuploidy in 631 cases of first trimester cystic
hygromas. Society for Maternal-Fetal Medicine. San Francisco, CA. February 2011.
 Al Ammari R, Kaplan J, Tanner CE, Iyer C, Heard A, Coletta J, Panda B, Scholl J, House MD,
Craigo SD, Wolfberg AJ, Obstetric Outcomes in Cases of First Trimester Cystic Hygroma.
Society for Maternal-Fetal Medicine. San Francisco, CA. February 2011.
 Al Ammari A, Kaplan J, Tanner C, Iyer C, Heard A, Coletta A, Panda B, Scholl J, House M,
Craigo S, Wolfberg A, Obstetric Outcomes in Cases of First Trimester Cystic Hygroma.
New England Perinatal Society, Newport, RI. March 2011.
 Al Ammari A, Kaplan J, Tanner C, Iyer C, Heard A, Coletta A, Panda B, Scholl J, House M,
Craigo S, Wolfberg A. Turner’s Syndrome is the Most Common Karyotype in Fetuses
With Extremely Large Cystic Hygromas Diagnosed in the First Trimester. New England
Perinatal Society, Newport, RI. March 2011.
 Tanner C, Al Ammari R, Heard A, Iyer C, Kaplan J, Coletta J, Scholl J, Panda B, House M,
Craigo S, Wolfberg A. Do septations matter? An enlarged cystic hygroma is more likely to
predict aneuploidy than a nuchal translucency of the same size. New England Perinatal
Society, Newport, RI. March 2011.
 Kaplan J, Al Ammari R, Tanner C, Heard A, Iyer C, Coletta J, Scholl J, Panda B, House M,
Craigo S, Wolfberg A. The Influence of Plurality on Termination Decisions in Cases of
Cystic Hygroma. New England Perinatal Society, Newport, RI. March 2011.
 Heard A, Iyer C, Coletta J, Panda B, Scholl J, Al Ammari R, Kaplan J, Tanner CE , House MD,
Craigo SD, Wolfberg AJ, The influence of nuchal translucency thickness on the risk of
structural abnormalities. New England Perinatal Society, Newport, RI. March 2011.
 Wolfberg A, Feeny K, Coleman C. Physician attitudes toward medical liability – a survey.
ACOG Annual Clinical Meeting. Washington, DC. May 2011.
 Wasserman A, Linde F, House M, Wolfberg A. Indigo Carmine: does it diffuse across intact
fetal membranes? ACOG Annual Clinical Meeting. Washington, DC. May 2011.
GRAND ROUNDS AND INVITED PRESENTATIONS:
• Thyroid disease and congenital anomalies. Grand Rounds, Department of GYN/OB, Johns
Hopkins. March 8, 2001
• Oral contraceptive pills and the risk of thrombosis. Grand Rounds, Department of
OB/GYN, Mass. General Hospital. April 30, 2002.
• The bladder flap. Grand Rounds, Department of OB/GYN, Brigham and Women’s Hospital.
November 20, 2002
• The non-persistent molar pregnancy. Grand Rounds, Department of OB/GYN, Brigham and
Women’s Hospital. December 17, 2003.
• Early prediction of molar-pregnancy persistence using hCG as a tumor marker. Resident
Research Day. Department of OB/GYN, Brigham and Women’s Hospital. June 18, 2004.
• Medical management of miscarriage. Ward-chief presentation, Department of OB/GYN,
Massachusetts General Hospital. January 27, 2005.
• Prevencion, evaluacion systemática y tratamiento de displasia del cerviz. Invited lecture.
Department of OB/GYN. Hospital Cesar Amador Molina, Matagalpa, Nicaragua. May 16,
2005.
• Manejo médico del aborto espontáneo. Invited Lecture. Department of OB/GYN. Hospital
Cesar Amador Molina, Matagalpa, Nicaragua. May 17, 2005.
• Genetic tests and other studies your patients may have ordered online. Mount Auburn
Hospital Quarterly Seminar. Framingham, MA. November 15, 2006.
• Marketing of genetic testing. Grand Rounds. Tufts-New England Medical Center,
Department of OB/GYN. November 20, 2006.
• Marketing of genetic testing. Grand Rounds. MetroWest Medical Center. Framingham,
MA. November 20, 2007.
• I’m a numerical mess. Online Ultrasound Grand Rounds. “Pediatrix University.” January
2007.
• Standardized patients in medical education: Part of the solution or part of the problem.
Ackerman symposium on moral values in medical education today. Harvard Medical
School, Boston, MA. May 7, 2007.
• It Just Ain’t Right. Online Ultrasound Grand Rounds. “Pediatrix University.” July 2008.
• The problem of late-term prematurity. Grand Rounds in collaboration with the March of
Dimes. Melrose-Wakefield Hospital. Departments of OB/GYN and Pediatrics. February
2009.
• Update on Fetal Monitoring. Grand Rounds. Winchester Hospital. Department of OB/GYN.
April 2009.
• Keynote address: The problem of late-term prematurity. Symposium on late-term
prematurity held by the March of Dimes.. Springfield, MA. Worcester, MA. Boston, MA.
September 2009
• Is it safe to be a late pretern infant? Grand Rounds with John Fiascone, MD in
collaboration with the Massachusetts March of Dimes, 2009 & 2010 given at Cape Cod
Hospital, MetroWest Medical Center, Winchester Hospital, Brockton Hospital, Charleton
Hospital, South Shore Hospital, Lowell Memorial Hospital.